Board Members
R. Gordon Douglas, Jr. MD (Chairman)
Consultant, Vaccine Research Center, National Institutes of Health
Hoosen Coovadia, MD
Victor Daitz Chair in HIV/AIDS Research, Doris Duke Medical Research Institute, Nelson R Mandela School of Medicine, University of KwaZulu-Natal
Ann M. Ginsberg, M.D., Ph.D
Head of Clinical Development, Global Alliance for TB Drug Development
Michel Gréco, MS, MBA
Former President and Chief Operating Officer, Sanofi Pasteur (formerly Pasteur Mérieux Connaught)
Peter Barton Hutt, LL.M.
Senior Counsel, Covington & Burling
David N. McMurray, MS, PhD
Regents Professor, Texas A&M University
Philip K. Russell, MD
Major General (Retired), US Army Medical Corps
Jerald C. Sadoff, M.D.
President & CEO, Aeras Global TB Vaccine Foundation
Vijay B. Samant, M.S., M.B.A.
President & CEO, Vical Inc.
M.M. Sharma, Ph.D.
Emeritus Professor of Emimence, University of Mumbai
Peter M. Small, MD
Senior Program Officer, Tuberculosis Global Health Program, Bill and Melinda Gates Foundation
Douglas B. Young, PhD
Fleming Professor of Microbiology, Chair, Department of Infectious Diseases & Microbiology, Director, Centre for Molecular Microbiology and Infection, Imperial College London
Kenneth H. Silverberg (Secretary)
Partner, Nixon Peabody LLP
|
|
|
